Dixon Technologies Q1 Results: Revenue at ₹156B, Net Profit Surges to ₹6.6B

2 min read     Updated on 31 Jul 2026, 03:26 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Dixon Technologies reported Q1 consolidated revenue of ₹156B, surpassing the prior year's ₹128.36B and the market estimate of ₹147.7B. Consolidated net profit surged to ₹6.6B against ₹2.25B YoY, significantly beating the ₹2.4B estimate, though EBITDA margin contracted to 3.03% from 3.76% YoY, missing the estimated 3.40%.

powered bylight_fuzz_icon
46455848

*this image is generated using AI for illustrative purposes only.

Dixon Technologies has reported its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, following a conference call held on Friday, July 31, 2026, at 16:30 IST. The company delivered a strong top-line performance, with consolidated revenue coming in at ₹156B against ₹128.36B in the same period last year, surpassing the market estimate of ₹147.7B. Consolidated net profit surged sharply to ₹6.6B compared to ₹2.25B year-on-year, well ahead of the estimated ₹2.4B. The results were discussed by key management including Mr. Atul Lall, Vice Chairman & Managing Director, and Mr. Saurabh Gupta, Director & Group CFO, with Tanay Shah of DAM Capital Advisors Ltd moderating the session.

Q1 Financial Highlights

The following table summarises Dixon Technologies' key consolidated financial metrics for the quarter:

Metric: Q1 Actual Q1 Estimate Q1 Prior Year
Revenue: ₹156B ₹147.7B ₹128.36B
EBITDA: ₹4.7B ₹5B ₹4.83B
EBITDA Margin: 3.03% 3.40% 3.76%
Consolidated Net Profit: ₹6.6B ₹2.4B ₹2.25B

While revenue and net profit significantly outperformed estimates, EBITDA came in at ₹4.7B, slightly below the prior year's ₹4.83B and the market estimate of ₹5B. Correspondingly, the EBITDA margin contracted to 3.03% from 3.76% year-on-year, and also fell short of the estimated 3.40%, indicating some pressure on operating profitability despite robust top-line growth.

Earnings Call and Regulatory Compliance

The conference call served as the primary mechanism for management to communicate with shareholders and analysts following the filing of quarterly results. In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dixon Technologies notified both the Bombay Stock Exchange and the National Stock Exchange of India Limited regarding the proceedings. The notice was signed by Ashish Kumar, President – Chief Legal Counsel & Group Company Secretary, on July 24, 2026.

Dial-In and Access Details

Investors and analysts were able to join the conference call via universal access numbers or through a dedicated passcode link, with the call accessible from all networks and countries. The following international timings were provided for global participants:

Region: Time Zone Local Time
Hong Kong: HKT 19:00
Singapore: SGT 19:00
UK: BST 12:00
USA: EDT 07:00

For further information, DAM Capital Advisors Limited provided contact details for Tanay Shah, including phone number +91 22 4202 2592 and email tanay@damcapital.in . The universal access numbers for the call were +91 22 6280 1384 and +91 22 7115 8285.

Historical Stock Returns for Dixon Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
+2.20%+3.13%-0.87%+25.57%-13.69%+252.79%

What specific operational or pricing factors contributed to the EBITDA margin contraction to 3.03% despite the significant revenue beat?

How does management plan to address the divergence between top-line growth and operating profitability in the upcoming quarters?

Will Dixon Technologies adjust its full-year guidance given the strong net profit surge but weaker-than-expected EBITDA performance?

Dixon-Vivo Joint Venture Could Face Delays Amid China's New Outbound Investment Regime

0 min read     Updated on 22 Jul 2026, 02:09 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

The Dixon-Vivo joint venture may be delayed due to China's new outbound investment regime, which could broadly affect India-China JV timelines. NDTV Profit reported the development, highlighting regulatory uncertainty for cross-border collaborations. No financial figures or revised timelines have been disclosed as part of this update.

powered bylight_fuzz_icon
46255154

*this image is generated using AI for illustrative purposes only.

The proposed joint venture between Dixon Technologies and Vivo may face delays as China's new outbound investment regime emerges as a potential regulatory hurdle for India-China collaborations, according to a report by NDTV Profit.

Regulatory Headwinds for India-China JVs

China's new outbound investment regime is being cited as a key factor that could slow down the formation and operationalisation of joint ventures between Indian and Chinese companies. The Dixon-Vivo partnership is among those potentially affected by this evolving regulatory landscape.

Impact on Dixon-Vivo Partnership

The Dixon-Vivo joint venture, which had been anticipated as a significant development in India's electronics manufacturing sector, now faces uncertainty owing to the regulatory changes on the Chinese side. NDTV Profit reported that the new framework governing outbound investments from China could introduce procedural and compliance-related delays for such cross-border arrangements.

No specific financial details, revised timelines, or official statements from either Dixon Technologies or Vivo have been provided in connection with the reported delay.

Historical Stock Returns for Dixon Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
+2.20%+3.13%-0.87%+25.57%-13.69%+252.79%

How might other pending India-China joint ventures in the electronics sector be impacted by this new regulatory regime?

Could this regulatory hurdle prompt Dixon Technologies to seek alternative partnerships with non-Chinese manufacturers?

What specific compliance or procedural changes under China's outbound investment rules are causing the delays?

More News on Dixon Technologies

Must Read Next

Corporate Actions

Fedbank Financial board to consider ₹2,500 crore debt raising on August 25 26 mins ago

Stocks

Dr. Lal Pathlabs launches subsidiary Dr. Lal Pathlabs Indomed in Tashkent 1 min ago
no imag found
Bajaj Housing Finance plans analyst and investor meetings on Aug 24 and 26 6 mins ago
Autoline Industries secures ₹110 crore order from Tata Motors for hatchback parts 6 mins ago
1 Year Returns:-13.69%